MLchartDataset catalogue

therapeutic triiodothyronine

Term · Oncology and biomedicine · MLC-T-ONC-017137

A therapeutic formulation of the primary physiologically active form of endogenous thyroid hormone. In vivo, triiodothyronine enters the nucleus and binds to nuclear thyroid hormone receptors that subsequently bind to thyroid response elements (TREs) located in target genes. Receptor binding by triiodothyronine in combination with recruited coactivators results in maximal transcriptional activation after binding to TREs; in general, binding of thyroid hormone receptor alone to TREs leads to repression of gene transcription.

Table 1. Record
IdentifierMLC-T-ONC-017137
FieldOncology and biomedicine
AbbreviationTherapeutic T3
SynonymsLiothyronine; L-Triiodothyronine; Triiodothyronine
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-017137",
  "term": "therapeutic triiodothyronine",
  "field": "Oncology and biomedicine",
  "definition": "A therapeutic formulation of the primary physiologically active form of endogenous thyroid hormone. In vivo, triiodothyronine enters the nucleus and binds to nuclear thyroid hormone receptors that subsequently bind to thyroid response elements (TREs) located in target genes. Receptor binding by triiodothyronine in combination with recruited coactivators results in maximal transcriptional activation after binding to TREs; in general, binding of thyroid hormone receptor alone to TREs leads to repression of gene transcription.",
  "abbreviation": "Therapeutic T3",
  "synonyms": [
    "Liothyronine",
    "L-Triiodothyronine",
    "Triiodothyronine"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/therapeutic-triiodothyronine/"
}

Record 16,270 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.